Virtu Financial LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$144.95 - $152.29 $23.2 Million - $24.3 Million	159,754 Added 11250.28%	161,174 $24.4 Million
Q2 2022 Aug 09, 2022	BUY	$83.14 - $145.99 $118,058 - $207,305	1,420 New	1,420 $207,000
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $475,270 - $667,879	-4,808 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$65.78 - $105.02 $316,270 - $504,936	4,808 New	4,808 $467,000
Q3 2020 Dec 11, 2020	SELL	$59.04 - $77.95 $742,309 - $980,065	-12,573 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$29.01 - $74.23 $364,742 - $933,293	12,573 New	12,573 $919,000
Q4 2019 Feb 04, 2020	SELL	$40.86 - $57.65 $262,280 - $370,055	-6,419 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$37.38 - $49.47 $239,942 - $317,547	6,419 New	6,419 $268,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.